首页> 外文期刊>海南医科大学学报(英文版) >Influences of laparoscopic radical correction of oophoroma combined with chemotherapy on tumor related factors and immunologic function levels
【24h】

Influences of laparoscopic radical correction of oophoroma combined with chemotherapy on tumor related factors and immunologic function levels

机译:腹腔镜卵巢癌根治术联合化疗对肿瘤相关因子和免疫功能水平的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To study the influence of laparoscopic radical correction of oophoroma combined with chemotherapy on Tumor related factors and immunologic function levels. Methods:Retrospective analyses the 95 cases of ovarian cancer in our hospital from January 2013 to September 2017, which were divided into the control group and the observation group. The patients in the observation group underwent laparoscopic ovarian cancer radical surgery, the control group underwent open radical resection of ovarian cancer, two patients were combined with TP chemotherapy, the levels of serum MMP-9, HE4, YKL-40, EPO, PRL, TSGF and T lymphocyte subsets (CD3+, CD4+, CD8+ and CD4+/CD8+) in two groups before and after treatment were detected and compared. Results: (1) Before treatment, there was no statistical difference between the levels of serum MMP-9, HE4, YKL-40, EPO, PRL, TSGF in the two groups; After treatment, the levels of serum MMP-9, HE4, YKL-40, EPO, PRL, TSGF in the control group were statistically significant compared with those before treatment in the same group, and the differences were statistically significant between the two groups. (2) Before treatment, there was no statistical difference between the levels of serum T lymphocyte subsets (CD3+, CD4+, CD8+, CD4+/CD8+) in the two groups; After treatment, the differences of serum CD3+, CD4+, CD8+, CD4+/CD8+ were statistically significant compared with those before treatment in the same group, but the differences were not statistically significant between the two groups. Conclusion: Chemotherapy in patients with ovarian cancer TP in laparoscopic radical resection after, can not only significantly improve the patient's serum MMP-9, HE4, YKL-40, EPO, PRL, TSGF level. Moreover, compared with the simple operation, this method does not significantly affect the T lymphocyte subsets of the patients, and is worthy of clinical application.
机译:目的:研究腹腔镜矫正卵巢瘤联合化疗对肿瘤相关因素和免疫功能水平的影响。方法:回顾性分析了2013年1月至2017年9月在2013年1月至2017年9月的95例卵巢癌病例,分为对照组和观察组。观察组的患者接受了腹腔镜卵巢癌根治性手术,对照组接受了卵巢癌的开放性激进切除,两名患者与TP化疗相结合,血清MMP-9,HE4,YKL-40,EPO,PRL,PRL,PRL检测到治疗前后两组TSGF和T淋巴细胞亚群(CD3 +,CD4 +,CD8 +和CD4 + / CD8 +)。结果:(1)治疗前,两组血清MMP-9,HE4,YKL-40,EPO,PRL,TSGF之间没有统计学差异;治疗后,与在同一组中治疗之前的治疗前相比,对照组中血清MMP-9,HE4,YKL-40,EPO,PRL,TSGF的水平与治疗前的那些相比,两组之间的差异统计学意义。 (2)治疗前,两组血清T淋巴细胞亚群(CD3 +,CD4 +,CD8 +,CD4 + / CD8 +,CD4 + / CD8 +)之间没有统计学差异;处理后,与在同一组中治疗之前的那些相比,血清CD3 +,CD4 +,CD8 +,CD4 + / CD8 +的差异有统计学意义,但两组之间的差异没有统计学意义。结论:化疗腹腔镜切除术后卵巢癌TP患者,不仅可以显着改善患者的血清MMP-9,HE4,YKL-40,EPO,PRL,TSGF水平。此外,与简单的操作相比,该方法不会显着影响患者的T淋巴细胞亚群,值得临床应用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号